When AbbVie introduced a single-tablet version of its blood cancer drug Imbruvica earlier this year, it pitched the new formula as easier and more convenient for patients who took the older version as often as four times a day.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,